{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-100776","form_type":"8-K","ticker":"CERT","cik":"0001827090","company_name":"Certara, Inc.","filed_at":"2021-08-05T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.921182+00:00","generated_at":"2026-06-29T21:58:03.201122+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Certara acquires Pinnacle 21 for $310M in cash and stock","bullets":["Enterprise value $310M: $250M cash + $60M in newly issued Certara shares.","Acquisition expected to be immediately accretive to revenue, revenue growth, and adjusted EBITDA margin.","Pinnacle 21 provides FDA/PMDA-required clinical data standardization software; 22 of top 25 pharma companies are customers.","Transaction unanimously approved; expected to close early Q4 2021 subject to regulatory approvals.","Deal expands Certara's biosimulation platform into data fitness and regulatory software."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-100776","json":"https://secwatch.observer/filing/0001104659-21-100776.json","markdown":"https://secwatch.observer/filing/0001104659-21-100776.md","text":"https://secwatch.observer/filing/0001104659-21-100776.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1827090/000110465921100776/0001104659-21-100776-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1827090/000110465921100776/tm2123444d2_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T21:58:03.201122+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}